Advance in the anti-tumor mechanism of triptolide

Zhongguo Zhongyao Zazhi

Volumn 34, Issue 16, 2009, Pages 2024-2026

  Luo, Yongwei ^a,b   Shi, Chang ^a   Liao, Mingyang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

Author keywords

Angiogenesis; Anti tumor mechanism; Apoptosis; Cell cycle; Triptolide

Indexed keywords

TRIPTOLIDE;

ANTINEOPLASTIC ACTIVITY; CHINESE MEDICINE; HUMAN; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DITERPENES; DRUGS, CHINESE HERBAL; EPOXY COMPOUNDS; HUMANS; NEOPLASMS; PHENANTHRENES; TRIPTERYGIUM;

EID: 70449127470     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Qian S Z, Xu Y, Zhang J W. Recent progress in research on Tripterygium: A male antifertility plant [J]. Contraception, 1995, 51(2):121.
2. Kupchan S M, Court W A , Dailey R G, et al. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii [J]. J Am Chem Soc, 1972, 94(20):7194.
3. Wei Y S, Adachi I. Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines [J]. Acta Pharmacol Sin, 1991, 12(5):406.
4. Yang S, Chen J, Guo Z, et al. Triptolide inhibits the growth and metastasis of solid tumors [J]. Mol Cancer Ther, 2003, 2(1):65.
5. Shamon L A, Pezzuto J M, Graves J M, et al. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii [J]. Cancer Lett, 1997, 112(1):113.
6. Frese S, Pimia F, Miescher D, et al. PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2 [J]. Oncogene, 2003, 22(35):5427.
7. Chan E W, Cheng S C, Sin F W, et al. Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines [J]. Toxicol Lett, 2001, 122(1):81.
8. Tengchaisri T, Chawengkirttikul R, Rachaphaew N, et al. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters[J]. Cancer Lett, 1998, 133(2):169.
9. Zhou G X, Ding X L, Huang J F, et al. Apoptosis of human pancreatic cancer cells induced by Triptolide[J]. World J Gastroentero, 2008, 14(10):1504.
10. Kiviharju T M, Lecane P S, Sellers RG, et al. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells[J]. Clin Cancer Res, 2002, 8(8):2666.
11. Fidler J M, Li K, Chung C, et al. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy[J]. Mol Cancer Ther, 2003, 2(9):855.
12. Chen C N, Hsieh F J, Cheng Y M, et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer[J]. J Surg Oncol, 2006, 94(3):226.
13. Cianchi F, Cortesini C, Fantappie O, et al. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer[J]. Clin Cancer Res, 2004, 10(8):2694. (Pubitemid 38509144)
14. Tong X M, Zheng S E, Jin J, et al. Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells[J]. Acta Biochim Biophys Sin, 2007, 39(2):85.
15. Westerheide S D, Kawahara T A, Orton K, et al. Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death[J]. J Biol Chem, 2006, 281(14):9616. (Pubitemid 43864680)
16. Lee K Y, Chang W, Qiu D, et al. PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells[J]. J Biol Chem, 1999, 274(19):13451. (Pubitemid 129518558)
17. Lee K Y, Park J S, Jee Y K, et al. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation[J]. Exp Mol Med, 2002, 34(6):462.
18. Lou Y J, Jin J, Wang Y G, et al. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells[J]. Leuk Res, 2005, 29(1):99.
19. Qiu D M, Zhao G H, Aoki Y K, et al. Immunosuppressant PG490(triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation[J]. J Biol Chem, 1999, 274(19):13443.
20. Jiang X H, Wong B C, Lin M C, et al. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells[J]. Oncogene, 2001, 20(55): 8009.
21. Choi Y J, Kim T G, Kim Y H, et al. Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells[J]. Biochem Pharmacol, 2003, 66(2):273.
22. Lala P K, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression[J]. Lancet Oncol, 2001, 2(3):149.
23. Hu K B, Liu Z H, Guo X H, et al. Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells[J]. Acta Pharmacol Sin, 2000, 22(7):651.